PPH icon

VanEck Pharmaceutical ETF
PPH

Overview Fund Activity

44 hedge funds and large institutions have $122M invested in VanEck Pharmaceutical ETF in 2018 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 19 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
44
Holders Change
-5
Holders Change %
-10.2%
% of All Funds
1.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
6
Reduced
19
Closed
8
Calls
–
Puts
$1.04M
Net Calls
-$1.04M
Net Calls Change
-$122K

Top Buyers

1
Janney Montgomery Scott
Janney Montgomery Scott
Pennsylvania
+$360K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$131K
3
UBS Group
UBS Group
Switzerland
+$61.3K
4
APP
Avantax Planning Partners
Iowa
+$48K
5
LPL Financial
LPL Financial
California
+$40.4K

Top Sellers

1
BCI
Brinker Capital Investments
Pennsylvania
-$8.67M
2
Morgan Stanley
Morgan Stanley
New York
-$2.05M
3
VF
Virtu Financial
New York
-$2.02M
4
Citadel Advisors
Citadel Advisors
Florida
-$1.67M
5
TRCT
Tower Research Capital (TRC)
New York
-$1.5M
Name Holding Trade Value Shares
Change 		Shares
Change %
CF
51
Centaurus Financial
California
– -$1K -16 Closed
1 2
3